Abstract:Frontotemporal dementia (FTD) is a fatal neurodegenerative disease characterized by changes in social and emotional behavior. The disease can be caused by mutations in GRN that result in haploinsufficiency of the neuronal and microglial protein progranulin. Recent findings using Grn-/- mice have directed attention to progranulin's function in microglia and its contribution to neuroinflammation. Grn-/- mice have FTD-related behavioral deficits and gliosis similar to the human disease, however they do not model progranulin haploinsufficiency. We sought to determine the relative effects of progranulin insufficiency on neurons and microglia in mouse models. In this study we tested the behavior, physiology, neuropathology, inflammatory mediators, and neuronal morphology in Grn+/- mice at different ages to investigate the relationship between neuroinflammation and neuronal dysfunction in FTD. Grn+/- mice displayed FTD-related behavioral deficits, similar to Grn-/- mice, without neuroinflammation. We found reduced social behavior in Grn+/- and Grn-/- mice using the three-chamber sociability test. This social deficit was constant between multiple cohorts on two separate genetic backgrounds and appeared to be age-dependent, with deficits emerging after 4 months. In addition to the three-chamber test, we observed abnormal social behavior in Grn+/- mice using the tube test of social dominance. We also found emotional impairments in Grn+/- and Grn-/- mice, evident by decreased freezing in a classical fear-condition paradigm. Whereas social/emotion impairment was clear, we found no hippocampal-dependent behavioral or electrophysiological impairment in Grn+/- mice. This is consistent with the relative preservation of other cognitive domains early in FTD.Gliosis and increased TNF-Î ± mRNA levels were not observed in Grn+/- mice, unlike Grn-/- mice, demonstrating a dissociation of neuroinflammation and neuronal dysfunction. Therefore, we analyzed neuronal morphology and found that Grn+/- mice, as well as Grn-/- mice, displayed abnormal dendritic architecture in the amygdala, a region that controls social/emotional behavior and is implicated in FTD. Our results demonstrate that neuroinflammation and microglial involvement are not a driving force in FTD due to progranulin haploinsufficiency and suggest a vital role for progranulin in neurons. Also, Grn+/- mice are a useful tool in studying the behavioral deficits in FTD.

Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results

Rescue of FTLD-associated TDP-43 pathology and neurodegeneration by peripheral AAV-mediated expression of brain-penetrant progranulin

Peripheral expression of brain-penetrant progranulin rescues pathologies in mouse models of frontotemporal lobar degeneration

Progranulin as a therapeutic target in neurodegenerative diseases

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities

Neuronal Effects of Progranulin Deficiency Contribute to Frontotemporal Dementia Independent of Neuroinflammation

An Alternative In Vitro Model Of Neurodegeneration In Ftld-U With Pgrn Mutation

Lysosomal functions of progranulin and implications for treatment of frontotemporal dementia

Progranulin Protects Against Amyloid Β Deposition and Toxicity in Alzheimer’s Disease Mouse Models

Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia

Losing protein in the brain: the case of progranulin

Disease and Region Specificity of Granulin Immunopositivities in Alzheimer Disease and Frontotemporal Lobar Degeneration.

Induced Pluripotent Stem Cell Models of Progranulin-Deficient Frontotemporal Dementia Uncover Specific Reversible Neuronal Defects.

Identification of biological pathways regulated by PGRN and GRN peptide treatments using transcriptome analysis

A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

Lipid Dysregulation Unveil the Intricate Interplay of Lysosomal and Mitochondrial Changes in Frontotemporal Dementia with GRN Haploinsufficiency

Pathogenic cysteine mutations affect progranulin function and production of mature granulins.

Frontotemporal Dementia Patient Neurons With Progranulin Deficiency Display Protein Dyshomeostasis

Dissociation of Frontotemporal Dementia–Related Deficits and Neuroinflammation in Progranulin Haploinsufficient Mice

Carboxy-terminal blockade of sortilin binding enhances progranulin gene therapy, a potential treatment for frontotemporal dementia

Restoration of progranulin expression rescues cortical neuron generation in an induced pluripotent stem cell model of frontotemporal dementia